Categories: Market News

Avon’s stock rallies on Natura deal

Shares of Avon Products Inc. (NYSE: AVP) are continuing their rally from a day ago when the company announced its acquisition by Brazilian cosmetics firm Natura & Co. The stock was up 7% in morning hours on Thursday. It had climbed as much as 12% earlier in the day.  

On Wednesday, Natura announced it was acquiring Avon in an
all-stock transaction. The offer of 0.30 Natura Holding shares for each share
of Avon common stock values Avon at more than $2 billion. The transaction is
expected to be completed in early 2020 and will create the fourth-largest beauty
company in the world.

A new Brazilian holding company, Natura Holding S.A., has
been created for the deal. Natura shareholders will own approx. 76% of the
combined company while Avon shareholders will own around 24%. The combined
company is expected to have annual gross revenues of over $10 billion and a
geographic presence spanning 100 countries.

Natura expects the deal will generate annual synergies in
the range of $150 million to $250 million which will be reinvested in R&D
initiatives and expansion efforts.

Earlier this month, Avon reported its first quarter results
in which total revenue declined 15% year-over-year to $1.18 billion. The
company reported a wider net loss of $32.7 million, or $0.09 per share, versus
the prior-year period.

Avon’s stock has gained 150% year-to-date and looking at the past one year, shares have climbed 97%.

Follow our Google News edition to get the latest stock market, earnings and financial news at your fingertips.

Share
Published by

Recent Posts

S&P Global (SPGI) reports double-digit growth in Q4 adj. earnings; revenue up 9%

S&P Global (NYSE: SPGI), a leading provider of financial intelligence solutions, reported strong earnings growth…

19 minutes ago

Fiserv (FISV) Earnings: 4Q25 Key Numbers

Fiserv Inc. (NASDAQ: FISV) reported its fourth quarter 2025 earnings results today. Revenue increased 1%…

32 minutes ago

Incyte Corporation Reports Strong 2025 Fiscal Results and Provides 2026 Guidance

Incyte achieved total revenue of $5.14 billion for the full year 2025, a 21% year-over-year…

34 minutes ago

CVS Health Reports Record 2025 Revenue of $402.1 Billion and Reaffirms 2026 Earnings Guidance

CVS Health Corporation (NYSE: CVS) reported record full-year 2025 consolidated revenues of $402.1 billion, a…

58 minutes ago

CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline

Healthcare solutions company CVS Health Corporation (NYSE: CVS) on Monday reported an increase in revenues…

1 hour ago

DuPont Reports 2025 Full-Year Results and Issues 2026 Guidance Following Strategic Spinoffs

The industrial materials manufacturer reported flat fourth-quarter sales and a full-year organic growth rate of…

1 hour ago